Study drug DFP-14927 for advanced solid tumors
Part of Cancer clinical trials.
This Phase 1 trial tests DFP-14927, a new study drug, in adults with advanced solid tumors that have not responded to standard treatments. It’s designed to see if the drug is safe and to learn how it works in people with limited treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have a confirmed solid tumor (found by biopsy or fluid test).
- Your cancer has either come back after standard treatment or standard drug treatment is not expected to work well (or, for certain expansion groups, you have specific GI cancers).
- Your general health is good enough for trial treatment (ECOG performance status 0 or 1).
- Your blood and organ tests meet safety thresholds (enough white blood cells, platelets, hemoglobin, and acceptable kidney/liver/clotting results).
- You don’t have major uncontrolled health problems (like uncontrolled infection, unstable heart problems, or uncontrolled diabetes).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SON-DP for people with advanced solid tumors that haven't responded to standard treatments. It aims to see if the drug is safe and helps shrink or control the cancer.
This trial tests a new drug called DR30206 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and how the body processes it.
This trial tests a new drug called FTL001 for people with advanced solid tumors that have not improved with standard therapy. The goal is to see if it is safe and how well it works.
This trial tests a new drug called DB-1419 for people with advanced solid tumors that have not responded to other treatments. It is designed to target a protein called B7-H3 on cancer cells, and may help shrink tumors or slow their growth.
This trial tests a new drug called DNP002 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if DNP002 is safe and can help shrink tumors or slow their growth.
This trial tests a new drug called LPM6690176 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and how it affects the body.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.